MTND3P19

Across TCGA pan-cancer cohorts, MTND3P19 RNA is linked to patient survival in 16 of 34 cancer types, making it the most broadly survival-associated MTND3P19 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher MTND3P19 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated MTND3P19 expression acts as an unfavorable survival marker, although some lineages such as BLCA and KIRP show a favorable association.

BLCA, PAAD, and KIRP are the cancer types where MTND3P19 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	DFS	Tertile	II,III,IV	0.680	0.463	<.001	93	view →
PAAD	DFS	Tertile	II,III,IV	0.248	0.473	<.001	27	view →
KIRP	DFS	Median	All	0.970	0.883	.007	26	view →
THYM	DFS	Tertile	II,III,IV	0.641	0.908	.009	21	view →
LUSC	DFS	Tertile	All	0.578	0.679	.031	19	view →
THCA	OS	Tertile	All	0.995	0.964	.017	16	view →
UCEC	OS	Tertile	All	0.657	0.698	.026	16	view →
UVM	DFS	Tertile	All	0.645	0.389	.029	12	view →
KIRC	DFS	Tertile	IV	0.223	0.444	.016	9	view →
LUAD	DFS	Tertile	All	0.655	0.264	.018	9	view →
ACC	DFS	Quartile	III,IV	0.300	0.686	<.001	6	view →
HNSC	DFS	Tertile	IV	0.254	0.485	.025	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 16 lineages.

MTND3P19–BLCA (DFS)

Open the BLCA breakdown →